Real-life effect of elexacaftor/tezacaftor/ivacaftor therapy on microbiological findings in patients with Cystic fibrosis

被引：0
|
作者：
Lucca, Francesca [1 ]
Cucchetto, Giulia [1 ]
Paiola, Giulia [1 ]
Volpiilaria, Sonia [1 ]
Meneghelli, Illaria [1 ]
Pintani, Emily [1 ]
Cipolli, Marco [1 ]
机构：
[1] Cyst Fibrosis Ctr, Verona, Italy
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.OA3775
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Outcomes of triple therapy (elexacaftor/tezacaftor/ivacaftor) in Cystic fibrosis-related diabetes: a real-life case study from a Brazilian reference center
    Zorron, M.
    Guerra-Junior, G.
    Alexandre Pascoa, M.
    Castilho, T.
    Coimbra Teixeira, L.
    Azarite Salomao, M. J.
    De Souza Paiva Borgli, D.
    Cristina Ropoli Bernardino, B.
    Neuenschwander Mendonca, M.
    Faganello Colombo, F.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 118 - 118
  • [32] Ivacaftor-elexacaftor-tezacaftor and tacrolimus combination in cystic fibrosis
    Smith, Megan
    Ryan, Kevin J.
    Gutierrez, Hector
    Sanchez, Luz Helena Gutierrez
    Anderson, Janaina Nogueira
    Acosta, Edward P.
    Benner, Kim W.
    Guimbellot, Jennifer S.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (01) : E8 - E10
  • [33] Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosis
    Zhang, Lijia
    Albon, Dana
    Jones, Marieke
    Bruschwein, Heather
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [34] The efficacy of Elexacaftor/Tezacaftor/Ivacaftor in patients with cystic fibrosis and advanced lung disease
    O'Carroll, O. M.
    O'Shea, K. M.
    Carroll, C.
    Grogan, B.
    Connolly, A.
    O'Shaughnessy, L.
    Nicholson, T.
    Gallagher, C. G.
    McKone, E. F.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 1) : S16 - S16
  • [35] Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis
    Nichols, David P.
    Paynter, Alex C.
    Heltshe, Sonya L.
    Donaldson, Scott H.
    Frederick, Carla A.
    Freedman, Steven D.
    Gelfond, Daniel
    Hoffman, Lucas R.
    Kelly, Andrea
    Narkewicz, Michael R.
    Pittman, Jessica E.
    Ratjen, Felix
    Rosenfeld, Margaret
    Sagel, Scott D.
    Schwarzenberg, Sarah Jane
    Singh, Pradeep K.
    Solomon, George M.
    Stalvey, Michael S.
    Clancy, John P.
    Kirby, Shannon
    Van Dalfsen, Jill M.
    Kloster, Margaret H.
    Rowe, Steven M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (05) : 529 - 539
  • [36] Is Elexacaftor/Tezacaftor/Ivacaftor Effective in Treating Sinonasal Disease in Patients with Cystic Fibrosis?
    Merrill, Tyler B.
    Tyes, Jonathan
    Woodard, Troy D.
    LARYNGOSCOPE, 2024, 134 (02): : 501 - 503
  • [37] Elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and rare mutations
    Fainardi, Valentina
    Cresta, Federico
    Sorio, Claudio
    Melotti, Paola
    Pesce, Emanuela
    Deolmi, Michela
    Longo, Francesco
    Karina, Kleinfelder
    Esposito, Susanna
    Pisi, Giovanna
    PEDIATRIC PULMONOLOGY, 2024, 59 (12) : 3383 - 3390
  • [38] Papilledema and hypervitaminosis A after elexacaftor/tezacaftor/ivacaftor for cystic fibrosis
    Miller, Matthew J.
    Foroozan, Rod
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2022, 57 (01): : E6 - E10
  • [39] Early insurance coverage of elexacaftor/tezacaftor/ivacaftor for cystic fibrosis
    Anderson, Ashlee
    McCoy, Lindsey
    Pettit, Rebecca S.
    Wright, Brittany A.
    Lubsch, Lisa
    PEDIATRIC PULMONOLOGY, 2021, 56 (12) : 4053 - 4054
  • [40] Heterogeneity in response to Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis
    Alicandro, Gianfranco
    Gramegna, Andrea
    Bellino, Federica
    Sciarrabba, Sathya Calogero
    Lanfranchi, Chiara
    Contarini, Martina
    Retucci, Mariangela
    Blasi, Francesco
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (06) : 1072 - 1079
12345